Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches

por Mohammed, Omima S., Attia, Hany G., Mohamed, Bassim M. S. A., Elbaset, Marawan A., Fayed, Hany M.
Publicado 2023

Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway

por Elbaset, Marawan A., Mohamed, Bassim M. S. A., Gad, Shaimaa A., Afifi, Sherif M., Esatbeyoglu, Tuba, Abdelrahman, Sahar S., Fayed, Hany M.
Publicado 2023

Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways

por Elbaset, Marawan A., Mohamed, Bassim M. S. A., Moustafa, Passant E., Mansour, Dina F., Afifi, Sherif M., Esatbeyoglu, Tuba, Abdelrahman, Sahar S. M., Fayed, Hany M.
Publicado 2023